Differentiation of MEFs: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Protocol==Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs) | ==Protocol== | ||
==Strains==Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs | Adipogenic Differentiation of Mouse Embryonic Fibroblasts (MEFs) | ||
==Source==DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA) | ==Strains== | ||
Wild type (Tsc2 +/+) and Tsc2 -/- (p53−/−) MEFs | |||
==Source== | |||
DJ Kwiatkowski (Brigham and Women's Hospital, Boston, MA) | |||
==Papers== | ==Papers== | ||
• Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. | • Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, et al. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells. Hum Mol Genet 11: 525–534. | ||